Item 8.01 Other Events.
On July 9, 2014, Amarantus Bioscience Holdings, Inc. (the "Company") met the
conditions to call its outstanding warrants to purchase shares of its common
stock at an exercise price of $0.06 per share issued in the Company's private
placement offering completed on September 3, 2013 and September 26, 2013 (the
"Original Warrants"). The Company will provide notice on or about July 10, 2014
to the holders of the Original Warrants to call the warrants for cancellation at
a price of $0.001 per warrant share. As of the date hereof, there are 20,138,810
outstanding Original Warrants. Pursuant to the terms of the Original Warrants,
the Company will honor any exercise notices it receives before the 10 trading
after the call notice is received by the holders. If the Original warrants are
exercised the Company will receive an aggregate of approximately $1,208,329.
On July 9, 2014, the Company also met the conditions to force the conversion of
its outstanding 8% Original Issue Discount Senior Convertible Debentures due
September 6, 2014 and October 1, 2014 (the "Debentures"). As of the date hereof,
the Company has a principal aggregate amount of $166,667 Debentures outstanding.
The Company intends to provide notice to the holders of the Debentures on or
about July 10, 2014 to force such conversion.